Comparable Immune Function Inhibition by the Infliximab Biosimilar CT-P13: Implications for Treatment of Inflammatory Bowel Disease.
Lim KJ, Lee SJ, Kim S, Lee SY, Lee MS, Park YA, Choi EJ, Lee EB, Jun HK, Cho JM, Lee S, Kwon KS, Lim BP, Jeon MS, Shin EC, Choi YS, Fudim E, Picard O, Yavzori M, Ben-Horin S, Chang SJ.
Lim KJ, et al. Among authors: cho jm.
J Crohns Colitis. 2017 May 1;11(5):593-602. doi: 10.1093/ecco-jcc/jjw183.
J Crohns Colitis. 2017.
PMID: 28453766